Recent reviews of clinical trials in individuals with overweight or obesity suggest that intermittent severe energy restriction results in equivalent–albeit not superior—weight or fat loss and improvements in cardiovascular disease risk factors and fasting circulating insulin levels and insulin sensitivity (as assessed by homeostatic model assessment for insulin resistance, HOMA-IR) relative to moderate continuous energy restriction [17–20]. This evidence concerns the gene INS and Insulin resistance.